UPDATE 1-Lilly long-acting insulin delayed by liver concerns
February 23, 2015 at 11:35 AM EST
Feb 23 (Reuters) - Eli Lilly and Co said it would postpone by at least two years the marketing application for its once-daily diabetes treatment to evaluate liver concerns, a delay some analysts said could doom the experimental drug.
